受强制性开放获取政策约束的文章 - Brian A Van Tine了解详情
无法在其他位置公开访问的文章：3 篇
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
SP D'Angelo, MR Mahoney, BA Van Tine, J Atkins, MM Milhem, ...
The Lancet Oncology 19 (3), 416-426, 2018
强制性开放获取政策： US National Institutes of Health
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
D Adkins, J Ley, P Neupane, F Worden, AG Sacco, K Palka, ...
The lancet oncology 20 (9), 1295-1305, 2019
强制性开放获取政策： US National Institutes of Health
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications
RC Pestana, J Roszik, R Groisberg, S Sen, BA Van Tine, AP Conley, ...
Current Problems in Cancer 45 (5), 100794, 2021
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
可在其他位置公开访问的文章：113 篇
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
强制性开放获取政策： US National Institutes of Health
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
强制性开放获取政策： US National Institutes of Health
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
强制性开放获取政策： US National Institutes of Health
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs …
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...
The Lancet Oncology 18 (11), 1493-1501, 2017
强制性开放获取政策： US National Institutes of Health
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353-360, 2012
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
强制性开放获取政策： US National Institutes of Health
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
强制性开放获取政策： US National Science Foundation, US National Institutes of Health
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
强制性开放获取政策： US National Institutes of Health
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
强制性开放获取政策： US National Institutes of Health
Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized …
GD Demetri, M Von Mehren, RL Jones, ML Hensley, SM Schuetze, ...
Journal of Clinical Oncology 34 (8), 786-793, 2016
强制性开放获取政策： US National Institutes of Health
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
强制性开放获取政策： US National Institutes of Health, Federal Ministry of Education and Research …
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
强制性开放获取政策： US National Institutes of Health
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines
K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ...
Cell systems 6 (3), 271-281. e7, 2018
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定